XML 42 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Quarterly Financial Data
12 Months Ended
Dec. 31, 2023
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Data Quarterly Financial Data (Unaudited)
Quarter Ended
March 31June 30September 30December 31Year
(In millions, except per share amounts)
Fiscal Year Ended December 31, 2023
Revenues$24,072 $25,190 $21,695 $22,978 $93,935 
Gross Profit2,080 1,883 1,810 1,740 7,513 
Net Earnings Attributable to Controlling Interests1,170 927 821 565 3,483 
Basic Earnings Per Common Share2.13 1.70 1.52 1.07 6.44 
Diluted Earnings Per Common Share2.12 1.70 1.52 1.06 6.43 
Quarter Ended
March 31
(Restated)
June 30
(Restated)
September 30
(Restated)
December 31
(Restated)
Year
(Restated)
Fiscal Year Ended December 31, 2023 (1)
(In millions)
Intersegment Revenues, as restated:
Ag Services and Oilseeds, as restated$530 $562 $594 $422 $2,108 
Carbohydrate Solutions, as restated270224232192918 
Nutrition, as restated1212111348 
Total Intersegment Revenues, as restated$812 $798 $837 $627 $3,074 
Segment Operating Profit, as restated:
Ag Services and Oilseeds, as restated$1,211 $1,054 $848 $954 $4,067 
Carbohydrate Solutions, as restated279 319 468 309 1,375 
Nutrition, as restated138 169 130 (10)427 
Total Segment Operating Profit, as restated$1,628 $1,542 $1,446 $1,253 $5,869 
Quarter Ended
March 31June 30September 30December 31Year
(In millions, except per share amounts)
Fiscal Year Ended December 31, 2022
Revenues$23,650 $27,284 $24,683 $25,939 $101,556 
Gross Profit1,897 2,100 1,811 1,762 7,570 
Net Earnings Attributable to Controlling Interests1,054 1,236 1,031 1,019 4,340 
Basic Earnings Per Common Share1.86 2.18 1.84 1.84 7.72 
Diluted Earnings Per Common Share1.86 2.18 1.83 1.84 7.71 
Quarter Ended
March 31
(Restated)
June 30
(Restated)
September 30
(Restated)
December 31
(Restated)
Year
(Restated)
Fiscal Year Ended December 31, 2022 (1)
(In millions)
Intersegment Revenues, as restated:
Ag Services and Oilseeds, as restated$404 $536 $597 $508 $2,045 
Carbohydrate Solutions, as restated267272233196968 
Nutrition, as restated1021171462 
Total Intersegment Revenues, as restated$681 $829 $847 $718 $3,075 
Segment Operating Profit, as restated:
Ag Services and Oilseeds, as restated$1,011 $1,119 $1,077 $1,194 $4,401 
Carbohydrate Solutions, as restated329 502 306 276 1,413 
Nutrition, as restated174 210 179 105 668 
Total Segment Operating Profit, as restated$1,514 $1,831 $1,562 $1,575 $6,482 

(1) Refer to Note 1 and Note 17 for further information on the Restatement related to Intersegment revenues and Segment Operating Profit.

Net earnings attributable to controlling interest for the second quarter of the year ended December 31, 2023 included after-tax gains of $8 million (equal to $0.02 per share) related to the sale of certain assets; after-tax charges of $93 million (equal to
$0.17 per share) related to the impairment of certain assets, restructuring, and a contingency loss provision related to import duties; after-tax expenses of $2 million (equal to $0.00 per share) related to certain acquisitions; an after-tax gain on debt conversion option of $1 million (equal to $0.00 per share) related to the mark-to-market adjustment of the conversion of the exchangeable bond issued in August 2020; and a tax expense adjustment of $21 million (equal to $0.04 per share) related to certain discrete items.

Net earnings attributable to controlling interest for the third quarter of the year ended December 31, 2023 included after-tax losses of $2 million (equal to $0.00 per share) related to the sale of certain assets; after-tax net charges of $54 million (equal to $0.10 per share) related to the impairment of certain assets and restructuring, partially offset by a contingency loss reversal; and after-tax expenses of $3 million (equal to $0.01 per share) related to certain acquisitions.

Net earnings attributable to controlling interest for the fourth quarter of the year ended December 31, 2023 included after-tax gains of $5 million (equal to $0.00 per share) related to the sale of certain assets; after-tax charges of $158 million (equal to $0.30 per share) related to the impairment of certain long-lived assets and goodwill and restructuring; after-tax expenses of $1 million (equal to $0.00 per share) related to certain acquisitions; and a tax expense adjustment of $1 million (equal to $0.00 per share) related to certain discrete items.

Net earnings attributable to controlling interest for the third quarter of the year ended December 31, 2022 included after-tax gains of $22 million (equal to $0.04 per share) related to the sale of certain assets; after-tax charges of $40 million (equal to $0.07 per share) related to the impairment of certain assets, restructuring, and settlement contingencies; an after-tax gain on debt conversion option of $8 million (equal to $0.01 per share) related to the mark-to-market adjustment of the conversion of the exchangeable bond issued in August 2020; and a tax expense adjustment of $7 million (equal to $0.01 per share) related to certain discrete items.

Net earnings attributable to controlling interest for the fourth quarter of the year ended December 31, 2022 included after-tax gains of $13 million (equal to $0.02 per share) related to the sale of certain assets; after-tax charges of $55 million (equal to $0.10 per share) related to impairment of certain assets, restructuring, and settlement contingencies; an after-tax loss on debt conversion option of $3 million (equal to $0.00 per share) related to the mark-to-market adjustment of the conversion of the exchangeable bond issued in August 2020; and a tax expense adjustment of $5 million (equal to $0.01 per share) related to certain discrete items.